10/11/2025
Public Alert No. 37/2025.
Alert on the Report of Substandard and Falsified (SF) BETACLOX found in Nigeria
https://bit.ly/4hPmxfD
NAFDAC is alerting the public to a suspected substandard and falsified (SF) pharmaceutical product identified within the drug supply chain. The product in question, BETACLOX (a combination of ampicillin and cloxacillin), contains fraudulent registration details and comes from an unverified source, posing significant risks to public health.
The SF product was procured from Gambori Market in Maiduguri metropolis, Borno State, by a distributor in Kano who subsequently sold it to a retail outlet in Zaria, Kaduna State. The retail outlet in Zaria reported the product as suspected SF, initiating this investigation.
Preliminary investigation revealed that the NAFDAC Registration Number (NRN) A4-4724 displayed on the SF product belongs to an entirely different product: Mebendazole 500mg, manufactured by Chi Ltd. This is a clear case of misappropriation of a registration number.
While the SF product packaging displays the address as “No. 128 MCC Road, Calabar,” verification against the PCN (Pharmacists Council of Nigeria) list of registered premises confirms that Freeview Pharmaceutical Ltd. is located at “No. 101 MCC Road, Calabar, Cross River State.” This discrepancy raises additional concerns about the product’s authenticity and the potential unauthorised use of the company’s name.
BETACLOX is a combination of ampicillin and cloxacillin. Ampicillin + Cloxacillin capsules are a fixed-dose combination drug used to treat bacterial infections of the respiratory tract, ear, nose and throat, urinary tract, skin and soft tissue, and gastrointestinal system.
Product Details:
•Product Name: BETACLOX (Ampicillin 250mg and Cloxacillin 250mg)
•Alleged Importer: Freeview Pharmaceutical Ltd.
•Address: No. 128 MCC Road, Calabar, Cross River State
•Manufacturer: Saeny Laboratory Pvt, Ltd, Elappunkal Junction, Kozhuvanal, Kerala, 864 423 India
•Batch No.: 230701
•Man. Date: 07/2023
•Exp. Date: 07/2026
•NAFDAC REG. NO: A4 4724
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an email to [email protected]